3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo(4,5-b)pyridin-2-yl)pyridin-2-amine,
ARQ 092,
Miransertib,
miransertib,
ARQ-092,
AKT inhibitor 2,
1313881-70-7,
ARQ 092 Free Base,
UNII-T1DQI1B52Y,
T1DQI1B52Y,
3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine,
3-[3-[4-(1-Azanylcyclobutyl)phenyl]-5-Phenyl-Imidazo[4,5-B]pyridin-2-Yl]pyridin-2-Amine,
Miransertib [INN],
Miransertib [USAN],
Miransertib [WHO-DD],
GTPL9429,
SCHEMBL2187875,
HNFMVVHMKGFCMB-UHFFFAOYSA-N,
BCP19821,
EX-A1268,
WHO 10490,
ZINC72315647,
CS-5377,
SB19688,
compound 21a [PMID: 27305487],
HY-19719,
J3.532.768A,
3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine,
2-Pyridinamine, 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo(4,5-b)pyridin-2-yl)-,
3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo(4,5-b)pyridin-2-yl)-2-pyridinamine,
6S1,
ARQ 092,
A16286,